{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:07:20Z","timestamp":1777432040917,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejogrb.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:30:19Z","timestamp":1566559819000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study"],"prefix":"10.1016","volume":"245","author":[{"given":"Marissa","family":"Frijlingh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"De Milliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter. J.K.","family":"Hehenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-2677","authenticated-orcid":false,"given":"Judith. A.F.","family":"Huirne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2019.08.002_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsgi.2004.10.008","article-title":"Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas","volume":"12","author":"Di Lieto","year":"2005","journal-title":"J Soc Gynecol Investig"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00006250-199404000-00013","article-title":"The Maine Women\u2019s Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain","volume":"83","author":"Carlson","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0015","first-page":"1","article-title":"Esmya: new measures to minimise risk of rare but serious liver injury","volume":"48522","author":"Agency","year":"2018","journal-title":"European Medicines Agency."},{"issue":"3","key":"10.1016\/j.ejogrb.2019.08.002_bib0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00404-010-1732-6","article-title":"Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist","volume":"284","author":"Ichigo","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1447-0756.2000.tb01334.x","article-title":"A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis","volume":"26","author":"Takeuchi","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0015-0282(99)00366-0","article-title":"Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles","volume":"72","author":"Palomba","year":"1999","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/014436100434703","article-title":"Differential efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment on pedunculated and degenerated myomas: a retrospective study of 630 women","volume":"20","author":"Furui","year":"2000","journal-title":"J Obstet Gynaecol (Lahore)"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5468\/ogs.2017.60.1.69","article-title":"Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0020-7292(90)90520-U","article-title":"Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata","volume":"33","author":"Benagiano","year":"1990","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0055","doi-asserted-by":"crossref","first-page":"834","DOI":"10.12669\/pjms.304.4219","article-title":"Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri)","volume":"30","author":"Tosun","year":"2014","journal-title":"Pak J Med Sci"},{"issue":"7","key":"10.1016\/j.ejogrb.2019.08.002_bib0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/01443610400009543","article-title":"Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study","volume":"24","author":"Venkatachalam","year":"2004","journal-title":"J Obstet Gynaecol (Lahore)"},{"issue":"2","key":"10.1016\/j.ejogrb.2019.08.002_bib0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.12891\/ceog1826.2015","article-title":"Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma","volume":"42","author":"Senol","year":"2015","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2011.07.031","article-title":"Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma","volume":"116","author":"Kriplani","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 4","key":"10.1016\/j.ejogrb.2019.08.002_bib0075","first-page":"S147","article-title":"The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women","volume":"89","author":"Jindabanjerd","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0080","first-page":"508","article-title":"Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels","volume":"69","author":"Goto","year":"1993","journal-title":"Lab Investig"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0020-7292(03)00127-9","article-title":"Doppler-ultrasound as a predictor of uterine fibroid response to GnRH therapy","volume":"82","author":"Kanelopoulos","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2019.08.002_bib0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0020-7292(00)00198-3","article-title":"GnRH agonist decreases endothelial nitric oxide synthase (eNOS) expression in leiomyoma","volume":"70","author":"Gokdeniz","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"17","key":"10.1016\/j.ejogrb.2019.08.002_bib0095","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2019.08.002_bib0100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/uog.14668","article-title":"Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study","volume":"45","author":"Czuczwar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/436174","article-title":"Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo","volume":"2012","author":"Horak","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/01443615.2017.1330323","article-title":"3D power Doppler in uterine fibroids; influence of gain, cardiac cycle and off-line measurement techniques","volume":"38","author":"Nieuwenhuis","year":"2018","journal-title":"J Obstet Gynaecol (Lahore)"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.6138","article-title":"Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment","volume":"32","author":"Raine-Fenning","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0120","first-page":"118","article-title":"3D Power Doppler vascular indices as a novel technique in assessing the outcome of minimally invasive techniques in uterine fibroids treatment","volume":"16","author":"Stepniak","year":"2017","journal-title":"Prz Menopauzalny"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1471-0528.14608","article-title":"Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study","volume":"125","author":"Nieuwenhuis","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0130","article-title":"Fibroid vascularisation assessed with 3D power Doppler as predictor for fibroid related symptoms and quality of life: a prospective cohort study","author":"Keizer","year":"2017","journal-title":"Submitted BJOG."},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/humrep\/deg213","article-title":"Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy","volume":"18","author":"Walocha","year":"2003","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2019.08.002_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcu.22208","article-title":"The use of 3D power Doppler ultrasound in the quantification of blood vessels in uterine fibroids: feasibility and reproducibility","volume":"43","author":"Nieuwenhuis","year":"2015","journal-title":"J Clin Ultrasound"},{"issue":"6","key":"10.1016\/j.ejogrb.2019.08.002_bib0145","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/uog.11155","article-title":"Does three-dimensional power Doppler ultrasound predict histopathological findings of uterine fibroids? A preliminary study","volume":"40","author":"Minsart","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2019.08.002_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1028-4559(09)60209-6","article-title":"Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog","volume":"45","author":"Chia","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1 Pt 1","key":"10.1016\/j.ejogrb.2019.08.002_bib0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9378(99)70140-7","article-title":"Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists","volume":"180","author":"Weeks","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ejogrb.2019.08.002_bib0160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/14728222.2011.616196","article-title":"The management of fibroids based on immunohistochemical studies of their pseudocapsules","volume":"15","author":"Tinelli","year":"2011","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2019.08.002_bib0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2019.08.002_bib0175","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2017.12.033","article-title":"Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy","volume":"222","author":"Brun","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2018.03.026","article-title":"Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate","volume":"224","author":"Yun","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2019.08.002_bib0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dep437","article-title":"Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy","volume":"25","author":"Khan","year":"2010","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ejogrb.2019.08.002_bib0195","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2019.08.002_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2019.08.002_bib0205","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0210","first-page":"285","article-title":"Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids","volume":"8","author":"Biglia","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejogrb.2019.08.002_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/jum.14573","article-title":"Influence of ulipristal acetate therapy on uterine fibroid-related symptoms and on uterine and fibroid volumes and vascularity indices assessed by ultrasound","author":"Baggio","year":"2018","journal-title":"J Ultrasound Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.08.002_bib0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519303707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519303707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:48:29Z","timestamp":1759556909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211519303707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S0301211519303707"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.08.002","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}